ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent diseaseNicoletta Colombo, Thaïs Baert, I. Belaroussi et al.|Annals of Oncology|2019Cited by 1.2k
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent diseaseJonathan A. Ledermann, Anna Fagotti, Xavier Matías‐Guiu et al.|Annals of Oncology|2024Cited by 277
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient dataPaul A. Cohen, Arjun Jeyarajah, Aime Powell et al.|Gynecologic Oncology|2019Cited by 121
A Strategy for Defining Biologically Relevant Levels of p53 Protein Expression in Clinical Samples with Reference to Endometrial NeoplasiaW. Glenn McCluggage, Peter A. Hall, L E Connolly et al.|International Journal of Gynecological Pathology|2005Cited by 60
Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trialFaiza Gaba, Sadiyah Robbani, Naveena Singh et al.|International Journal of Gynecological Cancer|2020Cited by 54